Overview

Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension

Status:
Unknown status
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the antihypertensive effect of AGSCT101 tablet in patient with stage 1 to 2 essential hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Ahn-Gook Pharmaceuticals Co.,Ltd
Treatments:
Antihypertensive Agents
Carvedilol